UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 243

Sortiert nach

Stereotactic body radiotherapy for oligometastases

The lancet oncology, 2013, Vol.14 (1), p.e28-e37

2013

Link zum Volltext

Verfügbarkeit prüfen

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

The New England journal of medicine, 2012-09, Vol.367 (10), p.895-903

2012

Link zum Volltext

Verfügbarkeit prüfen

Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist

The lancet oncology, 2014-03, Vol.15 (3), p.e139-e147

2014

Link zum Volltext

Verfügbarkeit prüfen

Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy

JNCI : Journal of the National Cancer Institute, 2020-02, Vol.112 (2), p.179-190

2020

Link zum Volltext

Verfügbarkeit prüfen

The Role of Hypofractionated Radiotherapy in Prostate Cancer

Current Oncology Reports, 2017-04, Vol.19 (4), p.30, Article 30

2017

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials

The lancet oncology, 2009-09, Vol.10 (9), p.872-876

2009

Link zum Volltext

Verfügbarkeit prüfen

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

Nature genetics, 2014-08, Vol.46 (8), p.891-894

2014

Link zum Volltext

Verfügbarkeit prüfen

Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort

European urology, 2016-06, Vol.69 (6), p.1028-1033

2016

Link zum Volltext

Verfügbarkeit prüfen

Dose–Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397

International journal of radiation oncology, biology, physics, 2010-03, Vol.76 (3), p.747-754

2010

Link zum Volltext

Verfügbarkeit prüfen

Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)

International journal of radiation oncology, biology, physics, 2010-07, Vol.77 (3), p.773-783

2010

Link zum Volltext

Verfügbarkeit prüfen

Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397)

Quality of life research, 2017-08, Vol.26 (8), p.2103-2116

2017

Link zum Volltext

Verfügbarkeit prüfen

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial

Trials, 2012-09, Vol.13 (1), p.168-168, Article 168

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies

European journal of cancer (1990), 2012-09, Vol.48 (14), p.2117-2124

2012

Link zum Volltext

Verfügbarkeit prüfen

Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials

Frontiers in oncology, 2020-07, Vol.10, p.1174

2020

Link zum Volltext

Verfügbarkeit prüfen

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial

Trials, 2009-06, Vol.10 (1), p.39-39, Article 39

2009

Link zum Volltext

Verfügbarkeit prüfen

Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy

Clinical cancer research, 2019-11, Vol.25 (21), p.6487-6500

2019

Link zum Volltext

Verfügbarkeit prüfen

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

The New England journal of medicine, 2017-07, Vol.377 (4), p.338-351

2017

Link zum Volltext

Verfügbarkeit prüfen

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

The Lancet (British edition), 2016-03, Vol.387 (10024), p.1163-1177

2016

Link zum Volltext

Verfügbarkeit prüfen

Comment on "Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients"

British journal of cancer, 2023-03, Vol.128 (5), p.711-712

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(240)
Mit Volltextzugriff
(231)

Publikationsform

Artikel
(243)

Sprache

Englisch
(243)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Humans
(171)
Life Sciences & Biomedicine
(171)
Male
(157)
Oncology
(118)
Prostate Cancer
(81)
Prostatic Neoplasms - Radiotherapy
(75)
Aged
(73)
Middle Aged
(73)
Radiology, Nuclear Medicine & Medical Imaging
(73)
Biological And Medical Sciences
(50)
Medical Sciences
(50)
Prostatic Neoplasms - Pathology
(44)
Radiotherapy Dosage
(38)
Treatment Outcome
(38)
Prostatic Neoplasms - Drug Therapy
(36)
Radiotherapy
(30)
Tumors
(29)
Adult
(26)
Nephrology. Urinary Tract Diseases
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Stereotactic body radiotherapy for oligometastases

Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist

Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy

The Role of Hypofractionated Radiotherapy in Prostate Cancer

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study

Dose–Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397

Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)

Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397)

Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial

Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies

Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial

Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Comment on "Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients"

Suchergebnisse filtern